Results 21 to 30 of about 219,914 (168)

Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients

Cells
Background: Studies investigating the long-term cellular immune response to SARS-CoV-2 mRNA vaccines in patients with inflammatory bowel disease (IBD) remain limited, particularly among those receiving immunosuppressive therapy. Methods: We prospectively
Luis Mayorga Ayala, Claudia Herrera-deGuise, Juliana Esperalba, Xavier Martinez-Gomez, Elena Céspedes Martinez, Xavier Serra Ruiz, Virginia Robles, Ernesto Lastiri, Zahira Perez, Elena Oller, Candela Fernandez-Naval, Mónica Martinez-Gallo, Francesc Casellas, Natalia Borruel   +13 more
doaj   +1 more source

The Establishment of a National Tissue Bank for Inflammatory Bowel Disease Research in Canada

Canadian Journal of Gastroenterology, 2003
The Crohn’s and Colitis Foundation of Canada (CCFC) has established a national bank for tissue, serum and blood from patients with inflammatory bowel disease (IBD).
Stephen M Collins, Kevin McHugh, Ken Croitoru, Micheal Howorth   +3 more
doaj   +1 more source

Sexual and reproductive health considerations in the care of young adults with inflammatory bowel disease: A multidisciplinary conversation

Health Care Transitions
The effects of inflammatory bowel disease (IBD) and the medications used to treat it on sexual and reproductive health can be significant, impacting the quality of life of patients across gender identities.
Sydney Reed, Amy K. Bugwadia, Sneha Dave, Hannah E. Wilson, Prathikka Ramesh, Hilary K. Michel   +5 more
doaj   +1 more source

Helminth Interactions with Bacteria in the Host Gut Are Essential for Its Immunomodulatory Effect

Microorganisms, 2021
Colonization by the benign tapeworm, Hymenolepis diminuta, has been associated with a reduction in intestinal inflammation and changes in bacterial microbiota. However, the role of microbiota in the tapeworm anti-inflammatory effect is not yet clear, and
Milan Jirků, Zuzana Lhotská, Lucia Frgelecová, Oldřiška Kadlecová, Klára Judita Petrželková, Evan Morien, Kateřina Jirků-Pomajbíková   +6 more
doaj   +1 more source

Providing LGBTQ+ affirming care to young adults with inflammatory bowel diseases

Health Care Transitions
Creating an affirming care environment for young adults with IBD in the LGBTQ+ community is an essential part of inflammatory bowel disease (IBD) care.
Cade Johnson, Sneha Dave, Sydney Reed, Victor Chedid, Lucy Laube, Laura Targownik   +5 more
doaj   +1 more source

Phenolic Compounds Impact on Rheumatoid Arthritis, Inflammatory Bowel Disease and Microbiota Modulation

Pharmaceutics, 2021
Non-communicable chronic diseases (NCDs) are nowadays the principal cause of death, especially in most industrialized nations. These illnesses have increased exponentially with the consumption of diets very high in fat and sugar, not to mention stress ...
Rosa Direito, João Rocha, Bruno Sepodes, Maria Eduardo-Figueira   +3 more
doaj   +1 more source

Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia—Lessons from Inflammatory Bowel Disease

Diagnostics
Iron deficiency and iron deficiency anaemia are common in inflammatory bowel disease (IBD), to the detriment of the patients’ quality of life. Since ferritin, as an acute-phase protein (APP), has limited diagnostic value in IBD, concurrent assessment of ...
Karima Farrag, Aysegül Aksan, Valëza Ademaj-Kospiri, Eleni Leventi, Jürgen Stein   +4 more
doaj   +1 more source

Clinical trials and young adults with inflammatory bowel disease

Health Care Transitions
Young adults (approximately 18–35 years) with inflammatory bowel disease (IBD) represent a distinct demographic with unique developmental and physiological characteristics, yet they are underrepresented in clinical trials.
Sneha Dave, Sydney Reed, Mara Shapiro, Yeabsira Taye, Isabela Hernandez, Navin Kariyawasam, Ildiko Mehes, Manasi Agrawal, Miguel Regueiro, Adam Faye, Jeremy Adler   +10 more
doaj   +1 more source

An updated review of gastrointestinal toxicity induced by PD-1 inhibitors: from mechanisms to management

Frontiers in Immunology, 2023
PD-1 inhibitors, as one of commonly used immune checkpoint inhibitors, enable T-cell activation and prevent immune escape by blocking the PD-1/PD-L1 signaling pathway.
Yiyu Cheng, Fangmei Ling, Junrong Li, Yidong Chen, Mingyang Xu, Shuang Li, Liangru Zhu   +6 more
doaj   +1 more source

Analysis of Clinical and Histopathological Findings in Microscopic Colitis

Türk Patoloji Dergisi, 2022
Objective: Microscopic colitis is a chronic inflammatory disorder characterized by a triad of chronic diarrhea, endoscopy without significant abnormality, and distinct histopathological features. Histopathologically, microscopic colitis is divided into 3
Gozde TOPEL, Ebru CAKIR, Ilgin AYDIN, Fatma Husniye DILEK, Aysegul AKDER SARI   +4 more
doaj   +1 more source